Press Release / Media Release
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith the press release pertaining to receipt of ANDA approval from USFDA for Irbesartan and Hydrochlorothiazide Tablets USP. Updates
Corrigendum to the Unaudited Financial Results for the quarter ended June 30, 2017 published in Business Standard and Sakal editions dated August 10, 2017. Outcome of Board Meeting
We would like to inform you that Board of Directors at its Meeting held today, i.e. Wednesday, August 9, 2017 approved the Unaudited Financial Results for the quarter ended June 30, 2017. enclosed please find herewith:- a. Unaudited Financial Results for the quarter ended June 30, 2017. b. Limited Review Report given by the statutory auditors for the quarter ended June 30, 2017.... Unichem Labs gets USFDA nod for hypertension drug
Unichem Laboratories has received approval from the US health regulator for losartan potassium and hydrochlorothiazide tablets, used in the treatment of hypertension and reduction in risk of strokes... Press Release
Unichem Laboratories receives ANDA approval from USFDA for Losartan Potassium And Hydrochlorothiazide tablets USP. Notice Of Board Meeting To Be Held On August 9, 2017.
This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 9, 2017 to interalia consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017. Further, in terms of the Company's Code of Conduct to Regulate, Conduct, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition... Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Unichem Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Shareholding for the Period Ended June 30, 2017
Unichem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here